Trial NCT01355575

View at ClinicalTrials.gov 
Org. Study IDs: 2010-021515-17
Secondary IDs: 10/H0711/58 2010-021515-17 45706

Last trial update was posted on 2020-10-28

MeSH Interventions

Rifaximin

MeSH Conditions

Fatty Liver Liver Diseases Non-alcoholic Fatty Liver Disease

Other Conditions

NAFLD Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis

Stopping Reasons

Primary endpoint data review concluded no further patients required.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID